|
|
||||||||
a Department of Thoracic and Cardiovascular Surgery, University of Muenster, Muenster, Germany
b Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany
c Department of Anesthesiology, University Hospital of Regensburg, Regensburg, Germany
d Department of Cardiothoracic Surgery, University Hospital of Regensburg, Regensburg, Germany
Accepted for publication March 1, 2010.
* Address correspondence to Dr Wiebe, Klinik für Thorax, Herz und Gefässchirurgie, Universitätsklinikum der Universität Muenster, Albert-Schweitzer-Strasse 33, Muenster 48149, Germany (Email: karsten.wiebe{at}ukmuenster.de).
Presented at the Forty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Francisco, CA, Jan 26–28, 2009.
Background: For support of pulmonary function during complex thoracic surgical procedures, especially in respiratory compromised patients, a pumpless interventional lung assist (iLA) was applied. Feasibility and effectiveness for this novel indication were evaluated.
Methods: Ten patients underwent thoracic surgery with respiratory support by iLA. Indication for iLA application was the need for intraoperative prolonged discontinuation of ventilation (tracheal surgery and lung resections after pneumonectomy [n = 6], and emergency procedures in patients with acute respiratory failure [n = 4]. The pumpless extracorporeal system was inserted percutaneously into the femoral blood vessels before surgery. Blood flow through the iLA, cardiac output, and gas exchange were monitored.
Results: In all patients, the surgical procedure was successfully performed because of the support by the pumpless iLA. Mean blood flow across the iLA was 1.58 ± 0.3 L/min (1.2 L/min to 2.2 L/min). Low-dose norepinephrine was required to maintain sufficient systemic blood pressure. There was a moderate improvement in oxygenation (49 mL/min transfer of O2) and a very efficient elimination of carbon dioxide (121 mL/min transfer of CO2). Thus, extended periods of apneic oxygenation were possible during surgery. The device was removed immediately after surgery in 6 patients. In 4 patients with severe respiratory insufficiency, the iLA was continued for a mean of 6.8 days to allow for protective postoperative ventilation.
Conclusions: The application of pumpless iLA was hemodynamically well tolerated, and allowed for safe procedures in respiratory compromised patients, avoiding the application and consequences of cardiopulmonary bypass or pump-driven extracorporeal membrane oxygenation.
This article has been cited by other articles:
![]() |
G. Lang, S. Taghavi, C. Aigner, R. Charchian, J. R. Matilla, A. Sano, and W. Klepetko Extracorporeal Membrane Oxygenation Support for Resection of Locally Advanced Thoracic Tumors Ann. Thorac. Surg., July 1, 2011; 92(1): 264 - 270. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |